American Diabetes Association Says Mifepristone Shown To Reduce A1C In Patients With Difficult-To-Control Type 2 Diabetes And Hypercortisolism

RefinitivMeno di 1 minuto di lettura

AMERICAN DIABETES ASSOCIATION: MIFEPRISTONE SHOWN TO REDUCE A1C IN PATIENTS WITH DIFFICULT-TO-CONTROL TYPE 2 DIABETES AND HYPERCORTISOLISM

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Accedi o crea un account gratuito per leggere queste notizie